Operating Income (Loss) in USD of NEVRO CORP from 2012 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
NEVRO CORP quarterly/annual Operating Income (Loss) history and change rate from 2012 to Q4 2024.
  • NEVRO CORP Operating Income (Loss) for the quarter ending 31 Dec 2024 was -$51,408,000.000, a 336% decline year-over-year.
  • NEVRO CORP Operating Income (Loss) for the twelve months ending 31 Dec 2024 was -$126,229,000.000, a 27.1% decline year-over-year.
  • NEVRO CORP annual Operating Income (Loss) for 2024 was -$126,229,000.000, a 27.1% decline from 2023.
  • NEVRO CORP annual Operating Income (Loss) for 2023 was -$99,308,000.000, a 1711% decline from 2022.
  • NEVRO CORP annual Operating Income (Loss) for 2022 was $6,164,000.000.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

NEVRO CORP Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 -$126,229,000 -$51,408,000 -$39,621,000 -3.4% 01 Oct 2024 31 Dec 2024 10-K 04 Mar 2025
Q3 2024 -$86,608,000 -$13,866,000 +$11,693,000 +45.7% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2024
Q2 2024 -$98,301,000 -$25,121,000 +$518,000 +2% 01 Apr 2024 30 Jun 2024 10-Q 06 Aug 2024
Q1 2024 -$98,819,000 -$35,834,000 +$489,000 +1.3% 01 Jan 2024 31 Mar 2024 10-Q 07 May 2024
Q4 2023 -$99,308,000 -$11,787,000 +$7,571,000 +39.1% 01 Oct 2023 31 Dec 2023 10-K 04 Mar 2025
Q3 2023 -$106,879,000 -$25,559,000 -$107,641,000 -1.3% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024
Q2 2023 $762,000 -$25,639,000 -$1,848,000 -7.8% 01 Apr 2023 30 Jun 2023 10-Q 06 Aug 2024
Q1 2023 $2,610,000 -$36,323,000 -$3,554,000 -10.8% 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024
Q4 2022 $6,164,000 -$19,358,000 +$6,857,000 +26.2% 01 Oct 2022 31 Dec 2022 10-K 04 Mar 2025
Q3 2022 -$693,000 $82,082,000 +$128,526,000 01 Jul 2022 30 Sep 2022 10-Q 01 Nov 2023
Q2 2022 -$129,219,000 -$23,791,000 -$8,028,000 -50.9% 01 Apr 2022 30 Jun 2022 10-Q 01 Aug 2023
Q1 2022 -$121,191,000 -$32,769,000 -$10,257,000 -45.6% 01 Jan 2022 31 Mar 2022 10-Q 26 Apr 2023
Q4 2021 -$110,934,000 -$26,215,000 -$25,340,000 -29% 01 Oct 2021 31 Dec 2021 10-K 23 Feb 2024
Q3 2021 -$85,594,000 -$46,444,000 -$42,895,000 -12.1% 01 Jul 2021 30 Sep 2021 10-Q 02 Nov 2022
Q2 2021 -$42,699,000 -$15,763,000 +$19,598,000 +55.4% 01 Apr 2021 30 Jun 2021 10-Q 03 Aug 2022
Q1 2021 -$62,297,000 -$22,512,000 +$555,000 +2.4% 01 Jan 2021 31 Mar 2021 10-Q 04 May 2022
Q4 2020 -$62,852,000 -$875,000 +$10,806,000 +92.5% 01 Oct 2020 31 Dec 2020 10-K 24 Feb 2021
Q3 2020 -$73,658,000 -$3,549,000 +$12,435,000 +77.8% 01 Jul 2020 30 Sep 2020 10-Q 08 Nov 2021
Q2 2020 -$86,093,000 -$35,361,000 -$8,801,000 -33.1% 01 Apr 2020 30 Jun 2020 10-Q 04 Aug 2021
Q1 2020 -$77,292,000 -$23,067,000 +$19,187,000 +45.4% 01 Jan 2020 31 Mar 2020 10-Q 05 May 2021
Q4 2019 -$96,479,000 -$11,681,000 -$3,078,000 -35.8% 01 Oct 2019 31 Dec 2019 10-K 24 Feb 2021
Q3 2019 -$93,401,000 -$15,984,000 -$6,747,000 -73% 01 Jul 2019 30 Sep 2019 10-K 24 Feb 2021
Q2 2019 -$86,654,000 -$26,560,000 -$18,359,000 -2.2% 01 Apr 2019 30 Jun 2019 10-K 24 Feb 2021
Q1 2019 -$68,295,000 -$42,254,000 -$26,552,000 -1.7% 01 Jan 2019 31 Mar 2019 10-K 24 Feb 2021
Q4 2018 -$41,743,000 -$8,603,000 -$6,431,000 -3% 01 Oct 2018 31 Dec 2018 10-K 25 Feb 2020
Q3 2018 -$35,312,000 -$9,237,000 -$4,819,000 -1.1% 01 Jul 2018 30 Sep 2018 10-K 25 Feb 2020
Q2 2018 -$30,493,000 -$8,201,000 +$1,737,000 +17.5% 01 Apr 2018 30 Jun 2018 10-K 25 Feb 2020
Q1 2018 -$32,230,000 -$15,702,000 -$2,651,000 -20.3% 01 Jan 2018 31 Mar 2018 10-K 25 Feb 2020
Q4 2017 -$29,579,000 -$2,172,000 +$4,097,000 +65.4% 01 Oct 2017 31 Dec 2017 10-K 21 Feb 2019
Q3 2017 -$33,676,000 -$4,418,000 -$2,546,000 -1.4% 01 Jul 2017 30 Sep 2017 10-K 21 Feb 2019
Q2 2017 -$31,130,000 -$9,938,000 -$4,015,000 -67.8% 01 Apr 2017 30 Jun 2017 10-K 21 Feb 2019
Q1 2017 -$27,115,000 -$13,051,000 -$4,034,000 -44.7% 01 Jan 2017 31 Mar 2017 10-K 21 Feb 2019
Q4 2016 -$23,081,000 -$6,269,000 +$6,875,000 +52.3% 01 Oct 2016 31 Dec 2016 10-K 22 Feb 2018
Q3 2016 -$29,956,000 -$1,872,000 +$15,837,000 +89.4% 01 Jul 2016 30 Sep 2016 10-K 22 Feb 2018
Q2 2016 -$45,793,000 -$5,923,000 +$13,252,000 +69.1% 01 Apr 2016 30 Jun 2016 10-K 22 Feb 2018
Q1 2016 -$59,045,000 -$9,017,000 +$3,322,000 +26.9% 01 Jan 2016 31 Mar 2016 10-K 22 Feb 2018
Q4 2015 -$62,367,000 -$13,144,000 -$6,038,000 -85% 01 Oct 2015 31 Dec 2015 10-K 23 Feb 2017
Q3 2015 -$56,329,000 -$17,709,000 -$11,211,000 -1.7% 01 Jul 2015 30 Sep 2015 10-K 23 Feb 2017
Q2 2015 -$45,118,000 -$19,175,000 -$11,714,000 -1.6% 01 Apr 2015 30 Jun 2015 10-K 23 Feb 2017
Q1 2015 -$33,404,000 -$12,339,000 -$5,098,000 -70.4% 01 Jan 2015 31 Mar 2015 10-K 23 Feb 2017
Q4 2014 -$28,306,000 -$7,106,000 -$571,000 -8.7% 01 Oct 2014 31 Dec 2014 10-K 29 Feb 2016
Q3 2014 -$27,735,000 -$6,498,000 -$1,136,000 -21.2% 01 Jul 2014 30 Sep 2014 10-K 29 Feb 2016
Q2 2014 -$26,599,000 -$7,461,000 -$1,270,000 -20.5% 01 Apr 2014 30 Jun 2014 10-K 29 Feb 2016
Q1 2014 -$25,329,000 -$7,241,000 -$178,000 -2.5% 01 Jan 2014 31 Mar 2014 10-K 29 Feb 2016
Q4 2013 -$25,151,000 -$6,535,000 01 Oct 2013 31 Dec 2013 10-K 18 Mar 2015
Q3 2013 -$5,362,000 01 Jul 2013 30 Sep 2013 10-K 18 Mar 2015
Q2 2013 -$6,191,000 01 Apr 2013 30 Jun 2013 10-K 18 Mar 2015
Q1 2013 -$7,063,000 01 Jan 2013 31 Mar 2013 10-K 18 Mar 2015

NEVRO CORP Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$126,229,000 -$26,921,000 -27.1% 01 Jan 2024 31 Dec 2024 10-K 04 Mar 2025
2023 -$99,308,000 -$105,472,000 -17.1% 01 Jan 2023 31 Dec 2023 10-K 04 Mar 2025
2022 $6,164,000 +$117,098,000 01 Jan 2022 31 Dec 2022 10-K 04 Mar 2025
2021 -$110,934,000 -$48,082,000 -76.5% 01 Jan 2021 31 Dec 2021 10-K 23 Feb 2024
2020 -$62,852,000 +$33,627,000 +34.9% 01 Jan 2020 31 Dec 2020 10-K 21 Feb 2023
2019 -$96,479,000 -$54,736,000 -1.3% 01 Jan 2019 31 Dec 2019 10-K 23 Feb 2022
2018 -$41,743,000 -$12,164,000 -41.1% 01 Jan 2018 31 Dec 2018 10-K 24 Feb 2021
2017 -$29,579,000 -$6,498,000 -28.2% 01 Jan 2017 31 Dec 2017 10-K 25 Feb 2020
2016 -$23,081,000 +$39,286,000 +63% 01 Jan 2016 31 Dec 2016 10-K 21 Feb 2019
2015 -$62,367,000 -$34,061,000 -1.2% 01 Jan 2015 31 Dec 2015 10-K 22 Feb 2018
2014 -$28,306,000 -$3,155,000 -12.5% 01 Jan 2014 31 Dec 2014 10-K 23 Feb 2017
2013 -$25,151,000 -$6,021,000 -31.5% 01 Jan 2013 31 Dec 2013 10-K 29 Feb 2016
2012 -$19,130,000 01 Jan 2012 31 Dec 2012 10-K 18 Mar 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.